SG Americas Securities
ELVN icon

SG Americas Securities’s Enliven Therapeutics ELVN Stock Holding History

SG Americas Securities’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$455K Sell
2025
Q2 		$730K Buy
2025
Q1 		$258K Sell
2024
Q4 		$374K Buy
2024
Q3 		$256K Buy
2024
Q2 		– Sell
2024
Q1 		$166K Sell
2023
Q4 		$187K Buy
2023
Q3 		$157K Buy
2020
Q4 		– Sell
2020
Q3 		$134K Buy